News
InvestorsHub on MSN38m
Niagen Bioscience Shares Climb Following Exclusive License for Parkinson’s TherapyNiagen Bioscience Inc. (NASDAQ:NAGE) saw its stock rise 2% after securing an exclusive global commercial license from Norway’s Haukeland University Hospital to develop its nicotinamide riboside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback